Cure My Disease

Don't miss your cure!

 Log in / Sign up

New prostate cancer drug HRS-7525 enters first human tests

NCT ID NCT07711184

Not yet recruiting Disease control Sponsor: Jiangsu HengRui Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests an experimental drug called HRS-7525 in men with advanced prostate cancer. The main goals are to check its safety, find the highest safe dose, and determine the best dose for future studies. Participants take the drug as tablets, and researchers monitor for side effects and how the drug moves through the body.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HRS-7525 tablets
What this could lead to
If successful, this could establish a safe dose of HRS-7525 for larger trials, potentially offering a new treatment option for advanced prostate cancer.
What could go wrong
This is a very early Phase 1 trial with a small number of participants, so safety and effectiveness are not yet known. The drug may not work or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Epworth Health

    Melbourne, Victoria, 3121, Australia

    Contact

  • Fudan University Shanghai Cancer Center

    Shanghai, Shanghai Municipality, 200032, China

    Contact

  • ICON Kurralta Park

    Adelaide, South Australia, 5037, Australia

    Contact

  • ICON South Brisbane

    Brisbane, Queensland, 4101, Australia

    Contact

  • John Flynn Private Hospital

    Gold Coast, Queensland, 4224, Australia

    Contact

  • Macquarie University Hospital

    Sydney, New South Wales, 2109, Australia

    Contact

  • Southern Oncology Research Uni(SOCRU)

    Adelaide, South Australia, 5042, Australia

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.